Abstract:Numerous epidemiological and scientific studies have consistently demonstrated that populations exposed to arsenic (As) concentrations ranging from >10 ppb to 2500 ppb in their drinking water face an elevated risk of urogenital cancers, with a particular emphasis on bladder cancer (BCa). Hence, the goal of the study is to investigate the underlying mechanisms that trigger malignant transformation in the bladder using physiologically relevant arsenic concentrations observed in BCa patients. In our results, we observed significantly elevated levels of arsenic in the urine of BCa patients, ranging from 20 to 50 mg/L, in stark contrast to the levels observed in healthy controls (>10 mg/L) and the recommended guidelines set by the Environmental Protection Agency (EPA) and Centers for Disease Control and Prevention (CDC). We used a median physiological concentration of arsenic (30 PPM) in drinking water-induced bladder hyperplasia in male and female mice over six months. Likewise, chronic exposure of healthy bladder epithelial cells (TRT-HU1) to similar arsenic concentrations (250nM:30 PPM) for 12 months resulted in malignant transformation, and arsenic-transformed cells (AsT) were capable of inducing tumors in xenografted and orthotopic models. Nonetheless, the molecular mechanism responsible for this malignancy remains to be elucidated. Our molecular analysis has pointed towards the activation of stem cells, notably ALDH1A1 (with a 50,000-fold increase), as a pivotal factor driving this transformation. Furthermore, our research has demonstrated that the activation of ALDH1A1 is contingent on the induction of Metal Response Element-Binding Transcription Factor-1 (MTF1). Consequently, silencing MTF1 inhibited the expression of ALDH1A1 and its associated malignant properties in As-transformed cells, strongly suggesting that MTF1 functions as the master regulator in As-induced bladder carcinogenesis. We have also observed similar molecular signatures (MTF1 and ALDH1A1 expression) in arsenic-exposed versus non-exposed mice and bladder cancer patients. In conclusion, our studies suggest that activation of stem cells is a critical step in arsenic-induced bladder carcinogenesis. Citation Format: Bhawna Tyagi, Mohit Vashishta, Neha Tyagi, Balaji Chandrasekaran, Vaibhav Shukla, Ashish Tyagi, Chendil Damodaran. Exposure of arsenic promotes malignant stemness and induces bladder malignancy in preclinical models [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 1473.

Arsenic activated GLUT1-mTORC1/HIF-1α-PKM2 positive feedback networks promote proliferation and migration of bladder epithelial cells

Arsenic Induces the Expressions of Angiogenesis-Related Factors Through PI3K and MAPK Pathways in SV-HUC-1 Human Uroepithelial Cells.

HER2 and Src Co-Regulate Proliferation, Migration and Transformation by Downstream Signaling Pathways in Arsenite-Treated Human Uroepithelial Cells.

Low concentration arsenite activated JAK2/STAT3 signal and increased proliferative factor expressions in SV-HUC-1cells after short and long time treatment.

Oxidative stress and MAPK involved into ATF2 expression in immortalized human urothelial cells treated by arsenic

Sodium Arsenite Induces Cyclooxygenase-2 Expression in Human Uroepithelial Cells Through MAPK Pathway Activation and Reactive Oxygen Species Induction

Inflammatory cytokine COX-2 mediated cell proliferation through increasing cyclin D1 expression induced by inorganic arsenic in SV-HUC-1 human uroepithelial cells

SLC1A5 regulates cell proliferation and self-renewal through β-catenin pathway mediated by redox signaling in arsenic-treated uroepithelial cells

Arsenic Induced Overexpression of Inflammatory Cytokines Based on the Human Urothelial Cell Model in Vitro and Urinary Secretion of Individuals Chronically Exposed to Arsenic

Arsenite Increases Cyclin D1 Expression Through Coordinated Regulation of the Ca2+/NFAT2 and NF-κB Pathways Via ERK/MAPK in a Human Uroepithelial Cell Line.

Gene expression profiles to analyze the anticancer and carcinogenic effects of arsenic in bladder cancer

ATF2 Partly Mediated the Expressions of Proliferative Factors and Inhibited Pro-Inflammatory Factors' Secretion in Arsenite-Treated Human Uroepithelial Cells.

Dimethylarsinic acid (DMA(V) ) changed the expressions of proliferative related factors and secretion of inflammatory cytokines in rat bladder.

Abstract 1473: Exposure of arsenic promotes malignant stemness and induces bladder malignancy in preclinical models

Elevated aerobic glycolysis driven by p62-mTOR axis promotes arsenic-induced oncogenic phenotypes in human mammary epithelial cells

Matrine Suppresses Arsenic-Induced Malignant Transformation of SV-HUC-1 Cells via NOX2

Mapping dynamic histone modification patterns during arsenic-induced malignant transformation of human bladder cells

MicroRNA-191, Regulated by HIF-2α, is Involved in EMT and Acquisition of a Stem Cell-Like Phenotype in Arsenite-Transformed Human Liver Epithelial Cells.

Gene expression and DNA methylation regulation of arsenic in mouse bladder tissues and in human urothelial cells

Epithelial to Mesenchymal Transition in Arsenic-Transformed Cells Promotes Angiogenesis Through Activating Β-Catenin–vascular Endothelial Growth Factor Pathway

Integration of microRNAome, proteomics and metabolomics to analyze arsenic-induced malignant cell transformation.